SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950133-06-000728
Filing Date
2006-02-14
Accepted
2006-02-14 14:41:29
Documents
2
Group Members
VENROCK ASSOCIATES II, L.P.VENROCK ENTREPRENEURS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w17560csc13g.htm SC 13G 70958
2 EXHIBIT 99.1 w17560cexv99w1.htm EX-99.1 4706
  Complete submission text file 0000950133-06-000728.txt   77716
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 06613110
SIC: 2834 Pharmaceutical Preparations